These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 2360620)
21. Modulation by superoxide anions of neutrophil-mediated platelet activation. Renesto P; Si Tahar M; Chignard M Biochem Pharmacol; 1994 Apr; 47(8):1401-4. PubMed ID: 8185647 [TBL] [Abstract][Full Text] [Related]
22. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes. Evangelista V; Piccardoni P; de Gaetano G; Cerletti C Thromb Haemost; 1992 Jun; 67(6):660-4. PubMed ID: 1509406 [TBL] [Abstract][Full Text] [Related]
23. Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene. Zatta A; Prosdocimi M; Bazzoni G; Dejana E; Del Maschio A Eur J Pharmacol; 1991 May; 198(1):97-100. PubMed ID: 1833211 [TBL] [Abstract][Full Text] [Related]
24. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. Stahl GL; Morse DS; Martin SL Am J Physiol; 1997 Jun; 272(6 Pt 1):C1821-8. PubMed ID: 9227410 [TBL] [Abstract][Full Text] [Related]
25. Plasma antiproteinase screen and neutrophil-mediated platelet activation. A major role played by alpha 1 antitrypsin. Chignard M; Hazouard E; Renesto P; Laine A; Guidet B; Offenstadt G Biochim Biophys Acta; 1994 Dec; 1224(3):433-40. PubMed ID: 7803500 [TBL] [Abstract][Full Text] [Related]
26. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). Chignard M; Selak MA; Smith JB Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8609-13. PubMed ID: 3464972 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal LYM-1 antibody-dependent cytolysis by human neutrophils exposed to GM-CSF: auto-regulation of target cell attack by cathepsin G. Ottonello L; Epstein AL; Mancini M; Dapino P; Dallegri F J Leukoc Biol; 2004 Jan; 75(1):99-105. PubMed ID: 14525961 [TBL] [Abstract][Full Text] [Related]
28. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2. Mulligan MS; Desrochers PE; Chinnaiyan AM; Gibbs DF; Varani J; Johnson KJ; Weiss SJ Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11523-7. PubMed ID: 7903451 [TBL] [Abstract][Full Text] [Related]
29. Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain. Involvement in the potentiation of platelet aggregation. Si-Tahar M; Pidard D; Balloy V; Moniatte M; Kieffer N; Van Dorsselaer A; Chignard M J Biol Chem; 1997 Apr; 272(17):11636-47. PubMed ID: 9111081 [TBL] [Abstract][Full Text] [Related]
30. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. Ho JS; Buchweitz JP; Roth RA; Ganey PE J Leukoc Biol; 1996 May; 59(5):716-24. PubMed ID: 8656057 [TBL] [Abstract][Full Text] [Related]
31. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation. Rajtar G; Marchi E; de Gaetano G; Cerletti C Biochem Pharmacol; 1993 Sep; 46(5):958-60. PubMed ID: 8373448 [TBL] [Abstract][Full Text] [Related]
32. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets. Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511 [TBL] [Abstract][Full Text] [Related]
33. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. Chertov O; Ueda H; Xu LL; Tani K; Murphy WJ; Wang JM; Howard OM; Sayers TJ; Oppenheim JJ J Exp Med; 1997 Aug; 186(5):739-47. PubMed ID: 9271589 [TBL] [Abstract][Full Text] [Related]
35. Chemoattractant-induced release of elastase by tumor necrosis factor-primed human neutrophils: auto-regulation by endogenous adenosine. Ottonello L; Amelotti M; Barbera P; Dapino P; Mancini M; Tortolina G; Dallegri F Inflamm Res; 1999 Dec; 48(12):637-42. PubMed ID: 10669115 [TBL] [Abstract][Full Text] [Related]
36. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors. Puri RN; Colman RW Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848 [TBL] [Abstract][Full Text] [Related]
37. Stimulated release of neutral proteinases elastase and cathepsin G from inflammatory rat polymorphonuclear leukocytes. Bray MA; McKearn-Smith C; Metz-Virca G; Bodmer JL; Virca GD Inflammation; 1987 Mar; 11(1):23-37. PubMed ID: 3032794 [TBL] [Abstract][Full Text] [Related]
38. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827 [TBL] [Abstract][Full Text] [Related]
39. Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production. Pinckard RN; Prihoda TJ J Leukoc Biol; 1996 Feb; 59(2):219-28. PubMed ID: 8603994 [TBL] [Abstract][Full Text] [Related]
40. Neutrophils promote the release of alpha-6-fucosyltransferase from blood platelets through the action of cathepsin G and elastase. Kamińska J; Musielak M; Nowicka A; Wozniewicz B; Kościelak J Biochimie; 2001 Aug; 83(8):739-42. PubMed ID: 11530205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]